ProteoNic, a leading provider of premium vector technology and services for production of biologics, and FyoniBio, a contract development organization for biopharmaceuticals, have entered into a technology licensing agreement. Under the agreement, FyoniBio gains worldwide, non-exclusive commercial rights for application of ProteoNic techno-logy in its proprietary CHOnamite platform. As a result, FyoniBio’s clients will profit […]

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a MedTech company that develops AI-powered workflow solutions, have established a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms.

Researchers at Kobe University and Hiroshima University have successfully developed a bio- marker that will enable Parkinson’s disease to be rapidly and inexpensively diagnosed from blood serum samples.

A remarkable discovery and collaborative effort have revealed a new type of triterpenes, a group of organic compounds which are an important source of many medicines. Until now, all triterpenes were believed to be derived from squalene, itself a type of triterpene. However, for the first time, researchers witnessed biosynthesis, the formation of complex compounds […]